Carasent
In this equity research report, analysts Anton Andersson and Nils Annborn takes a closer look at Carasent, a Nordic provider of modern EHR systems, enabling doctors to spend less time on administrative tasks and more time with patients.
Category: Fundamental Analysis
Oriola Corporation
In this equity research report, analysts Hugo Bogren and August Wigfors provide an in-depth analysis of Oriola Corporation, a pharmaceutical distributor operating in the highly regulated markets of Sweden and Finland.
ITAB
In this equity research report, Analysts Gabriel Koorits and Mandy Sy take a closer look at ITAB Shop Concept AB (ITAB), a European market leader in in-store solutions and retail technology.
Unlimited Travel Group (UTG)
In this equity research report, analysts Joel Persson and Oscar Persson provide a comprehensive analysis of Unlimited Travel Group (UTG), a Swedish event and travel agency group.
Harboes Bryggeri
In this equity research report, analysts Calle Alm-Ramberg and Nika Lundh take a closer look at Harboes Bryggeri, a Danish brewery holding 15% of the domestic beer market by volume.
Storytel Group AB
In this equity research report, analysts Albert Jansson and August Nõu Strömgren provide a detailed analysis of Storytel Group, the Nordic market leader in audiobook streaming and publishing.
Arla Plast
In this equity research report, analysts Rahil Hussain and Christian Carlsson take a closer look at Arla Plast AB. Arla Plast is a Swedish producer of extruded plastic sheets, serving a wide range of industries with different applications.
Karnov Group
In this equity research report, analysts William Voldseth and Elvira Husén present an in-depth fundamental analysis of Karnov Group, a market leader in digital tech offering a civil law database for the legal industry
Norditek Group (NOTEK)
In this financial analysis report, analysts Erik Mellander Wallin and Viktor Bergqvist take a closer look at Norditek Group, a company providing system solutions to the waste management sector in Sweden. The analysts estimate a revenue CAGR of 16.3% from 21/22A to 27/28E.
ContextVision (CONTX)
In this financial analysis report, analysts Philip Höglund and Caroline Danielsson take a closer look at ContextVision, the world-leading medical imaging company and the sole independent image analysis and enhancement software supplier. Following a spin-off of the Company’s cost burden division within digital pathology last year, thus the Analysts believe that the market seems to miss ContextVision’s highly profitable core business in medical imaging.In this financial analysis report, analysts Philip Höglund and Caroline Danielsson take a closer look at ContextVision, the world-leading medical imaging company and the sole independent image analysis and enhancement software supplier. Following a spin-off of the Company’s cost burden division within digital pathology last year, thus the Analysts believe that the market seems to miss ContextVision’s highly profitable core business in medical imaging.